The Division has an active research programme, which has three broad focus areas. Firstly, we conduct research around the development, evaluation and implementation of novel diagnostic tests for tuberculosis. Secondly, we host a satellite unit of the National Institute for Communicable Diseases, which focuses on the molecular epidemiology of drug-resistant nosocomial pathogens. Thirdly, we have a new interest in understanding the dynamics of the nasopharyngeal microbiome, and its relationship to childhood pneumonia and asthma. By adopting a research strategy that is based on investigating specific aspects of the physiology and metabolism of M. tuberculosis, the Molecular Mycobacteriology Research Unit (MMRU) has positioned itself at the front-end of TB drug discovery research
|Veronica Allen||PhD||The Development and Evaluation of Novel Diagnostic Tests for TB.||Prof Mark Nicol
Dr Lemese Ah Tow Edries
|Mischka Moodley||PhD||Investigation of novel TB diagnostics as point-of-care tests in low-income settings.||Prof Mark Nicol|
|Reggie Mutetwa||PhD||Preventing adverse outcomes in smear negative TB suspects in the era of collaborative TB and HIV programmes: the contribution of new TB diagnostics.||Prof Mark Nicol
Dr Elizabeth Corbett (LSHTM)
Prof Peter Mason (BRTI, Harare)
|Rajesh Sarkar||PhD||The innate immune response to Mycobacterium tuberculosis is dependent on strain lineage and on the host population.
An evaluation of a novel culture supplement to improve Mycobacterium tuberculosis growth in clinical specimens.
|Prof Mark Nicol
Prof Robert Wilkinson
|Shima Mohammed||MSc||Investigation of the genetic background of Staphylococcus aureus in the nasopharyngeal microbiome.||Prof Mark Nicol
Dr Eliya Madikane
|Felix Dube||MSc||Molecular epidemiology of nasopharyngeal carriage of Streptococcus pneumoniae in children less than 2 years of age from the Cape Winelands: Implications for vaccine strategies.||Prof Mark Nicol
Dr Mamadou Kaba